HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glasgow, W. C. Articles by Eling, T. E. Search for Related Content PubMed PubMed Citation Articles by Glasgow, W. C. Articles by Eling, T. E. Social Bookmarking                      What's this?

Volume 272, Number 31, Issue of August 1, 1997 pp. 19269-19276
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation
DIFFERENTIAL RESPONSE IN SYRIAN HAMSTER EMBRYO TUMOR SUPPRESSOR PHENOTYPES

(Received for publication, January 23, 1997, and in revised form, April 15, 1997)

Wayne C. Glasgow , Rutai Hui , Angela L. Everhart , Shiranthi P. Jayawickreme , Julie Angerman-Stewart , Bing-Bing Han and Thomas E. Eling

From the Eicosanoid Biochemistry Section, Laboratory of Molecular Carcinogenesis, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709 and  Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia 31207

In Syrian hamster embryo (SHE) fibroblasts, epidermal growth factor receptor (EGFR) tyrosine kinase activity regulates the metabolism of endogenous linoleic acid to (13S)-hydroperoxyoctadecadienoic acid (13S)-HPODE). (13S)-HPODE stimulates EGF-dependent mitogenesis in a SHE cell phenotype, which expresses tumor suppressor genes (supB⁺), but was not effective in a variant that does not express these suppressor genes (supB). In the present study, we have investigated the potential effects of this lipid metabolite on the EGFR signaling pathways in these two SHE cell lines. Treatment of quiescent SHE cells with EGF produced a rapid, transient increase in the tyrosine phosphorylation of EGFR. Dependence on EGF concentration for EGFR tyrosine phosphorylation was similar in both SHE cell lines, but a more prolonged phosphorylation was detected in the supB variant. Incubation of supB⁺ cells with (13S)-HPODE and EGF increased EGFR autophosphorylation and tyrosine phosphorylation on several signaling proteins with Src homology-2 domains including GTPase-activating protein. The lipid metabolite did not significantly alter EGF-dependent tyrosine phosphorylation in the supB variant. Tyrosine phosphorylation of mitogen-activated protein (MAP) kinase was also measured. The addition of (13S)-HPODE increased the extent and duration of MAP kinase tyrosine phosphorylation in supB⁺ cells but not in the supB variant. MAP kinase activity in supB⁺ cells, as measured in immunoprecipitates from cells after the addition of EGF, was increased by the presence of (13S)-HPODE. The addition of (13S)-HPODE did not directly alter EGFR kinase activity or the internalization of the EGFR. However, the addition of (13S)-HPODE to supB⁺ cells extended the tyrosine phosphorylation of the EGFR in response to EGF. The dephosphorylation of the EGFR was measured directly, and a slower rate was observed in the supB compared with the supB⁺ cells. Incubation of the supB⁺ cells with (13S)-HPODE attenuated the dephosphorylation of the EGFR. Thus, (13S)-HPODE stimulates EGF-dependent mitogenesis and up-regulation of EGF-dependent tyrosine phosphorylation by inhibiting the dephosphorylation of the EGFR. This study shows that a metabolite of an essential dietary fatty acid, linoleic acid, can modulate tyrosine phosphorylation and activity of key signal transduction proteins in a growth factor mitogenic pathway.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. E. Blask, G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer, M. A. Rivera-Bermudez, M. L. Dubocovich, S. A. Jasser, et al. Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats Cancer Res., December 1, 2005; 65(23): 11174 - 11184. [Abstract] [Full Text] [PDF]

				D. E. Blask, R. T. Dauchy, L. A. Sauer, and J. A. Krause Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin Carcinogenesis, June 1, 2004; 25(6): 951 - 960. [Abstract] [Full Text] [PDF]

				H. Ando, H. Watabe, J. C. Valencia, K.-i. Yasumoto, M. Furumura, Y. Funasaka, M. Oka, M. Ichihashi, and V. J. Hearing Fatty Acids Regulate Pigmentation via Proteasomal Degradation of Tyrosinase: A NEW ASPECT OF UBIQUITIN-PROTEASOME FUNCTION J. Biol. Chem., April 9, 2004; 279(15): 15427 - 15433. [Abstract] [Full Text] [PDF]

				H. Kameda, J. I. Risinger, B.-B. Han, S. J. Baek, J. C. Barrett, T. Abe, T. Takeuchi, W. C. Glasgow, and T. E. Eling Expression of Gab1 Lacking the Pleckstrin Homology Domain Is Associated with Neoplastic Progression Mol. Cell. Biol., October 15, 2001; 21(20): 6895 - 6905. [Abstract] [Full Text] [PDF]

				H. Kameda, J. I. Risinger, B.-B. Han, S. J. Baek, J. C. Barrett, W. C. Glasgow, and T. E. Eling Identification of Epidermal Growth Factor Receptor- Grb2-associated Binder-1-SHP-2 Complex Formation and Its Functional Loss during Neoplastic Cell Progression Cell Growth Differ., June 1, 2001; 12(6): 307 - 318. [Abstract] [Full Text] [PDF]

				N. Vacaresse, I. Lajoie-Mazenc, N. Auge, I. Suc, M.-F. Frisach, R. Salvayre, and A. Negre-Salvayre Activation of Epithelial Growth Factor Receptor Pathway by Unsaturated Fatty Acids Circ. Res., November 12, 1999; 85(10): 892 - 899. [Abstract] [Full Text] [PDF]

				L. A. Sauer, R. T. Dauchy, D. E. Blask, B. J. Armstrong, and S. Scalici 13-Hydroxyoctadecadienoic Acid Is the Mitogenic Signal for Linoleic Acid-dependent Growth in Rat Hepatoma 7288CTC in Vivo Cancer Res., September 1, 1999; 59(18): 4688 - 4692. [Abstract] [Full Text] [PDF]

				D. E. Blask, L. A. Sauer, R. T. Dauchy, E. W. Holowachuk, M. S. Ruhoff, and H. S. Kopff Melatonin Inhibition of Cancer Growth in Vivo Involves Suppression of Tumor Fatty Acid Metabolism via Melatonin Receptor-mediated Signal Transduction Events Cancer Res., September 1, 1999; 59(18): 4693 - 4701. [Abstract] [Full Text] [PDF]

				C. Xing and W. Imagawa Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF Carcinogenesis, July 1, 1999; 20(7): 1201 - 1208. [Abstract] [Full Text] [PDF]

				H. Ikawa, H. Kamitani, B. F. Calvo, J. F. Foley, and T. E. Eling Expression of 15-Lipoxygenase-1 in Human Colorectal Cancer Cancer Res., January 1, 1999; 59(2): 360 - 366. [Abstract] [Full Text] [PDF]

				H. Kamitani, M. Geller, and T. Eling Expression of 15-Lipoxygenase by Human Colorectal Carcinoma Caco-2 Cells during Apoptosis and Cell Differentiation J. Biol. Chem., August 21, 1998; 273(34): 21569 - 21577. [Abstract] [Full Text] [PDF]

				L. C. Hsi, L. Wilson, J. Nixon, and T. E. Eling 15-Lipoxygenase-1 Metabolites Down-regulate Peroxisome Proliferator-activated Receptor gamma via the MAPK Signaling Pathway J. Biol. Chem., September 7, 2001; 276(37): 34545 - 34552. [Abstract] [Full Text] [PDF]